for subscribers

Aspen continues spending spree with $372m purchase

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
(iStock)
(iStock)

Johannesburg - Aspen Pharmacare [JSE:APN] has agreed to buy a portfolio of anaesthetic medicines from GlaxoSmithKline for as much as $372m as Africa’s biggest maker of generic drugs continues a spending spree.

The company will pay an initial $239m to Glaxo and disburse as much as $133m if certain goals are met, the South Africa-based drugmaker said in a statement on Monday.

The deal adds to the anaesthetics Aspen bought in June from AstraZeneca of the UK for as much as $770m. 

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
ZAR/USD
17.08
(-0.14)
ZAR/GBP
21.76
(+0.05)
ZAR/EUR
19.91
(+0.24)
ZAR/AUD
12.04
(+0.49)
ZAR/JPY
0.16
(+0.25)
Gold
1853.26
(-0.09)
Silver
22.08
(+0.75)
Platinum
834.50
(+0.48)
Brent Crude
41.98
(+0.17)
Palladium
2215.50
(+0.53)
All Share
54247.81
(+1.84)
Top 40
50127.05
(+2.04)
Financial 15
9588.13
(+0.19)
Industrial 25
74229.70
(+3.26)
Resource 10
53508.98
(+1.08)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Do you think it was a good idea for the government to approach the IMF for a $4.3 billion loan to fight Covid-19?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes. We need the money.
11% - 1357 votes
It depends on how the funds are used.
73% - 8809 votes
No. We should have gotten the loan elsewhere.
16% - 1941 votes
Vote